🚀 VC round data is live in beta, check it out!
ScandiDos Valuation Multiples
Discover revenue and EBITDA valuation multiples for ScandiDos and similar public comparables like Spineway, Neola Medical, Bio-Gate, Qlife Holding and more.
ScandiDos Overview
About ScandiDos
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
Founded
2001
HQ
Employees
26
Website
Sectors
Financials (FY)
EV
$5M
ScandiDos Financials
ScandiDos reported last fiscal year revenue of $7M and EBITDA of $269K.
In the same fiscal year, ScandiDos generated $5M in gross profit, $269K in EBITDA, and $36K in net income.
ScandiDos P&L
In the most recent fiscal year, ScandiDos reported revenue of $7M and EBITDA of $269K.
ScandiDos expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $7M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 76% | XXX | XXX | XXX |
| EBITDA | — | XXX | $269K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 1% | XXX | XXX | XXX |
| Net Profit | — | XXX | $36K | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
ScandiDos Stock Performance
ScandiDos has current market cap of $6M, and enterprise value of $5M.
Market Cap Evolution
ScandiDos' stock price is $0.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $6M | 0.3% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialScandiDos Valuation Multiples
ScandiDos trades at 0.8x EV/Revenue multiple, and 19.9x EV/EBITDA.
ScandiDos Financial Valuation Multiples
As of April 20, 2026, ScandiDos has market cap of $6M and EV of $5M.
Equity research analysts estimate ScandiDos' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ScandiDos has a P/E ratio of 177.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 19.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 79.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.0x | XXX | XXX | XXX |
| P/E | — | XXX | 177.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (5.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ScandiDos Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
ScandiDos Margins & Growth Rates
ScandiDos' revenue in the last fiscal year grew by 1%.
ScandiDos' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
ScandiDos Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (219%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
ScandiDos Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| ScandiDos | XXX | XXX | XXX | XXX | XXX | XXX |
| Spineway | XXX | XXX | XXX | XXX | XXX | XXX |
| Neola Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio-Gate | XXX | XXX | XXX | XXX | XXX | XXX |
| Qlife Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucyd | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ScandiDos M&A Activity
ScandiDos acquired XXX companies to date.
Last acquisition by ScandiDos was on XXXXXXXX, XXXXX. ScandiDos acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by ScandiDos
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialScandiDos Investment Activity
ScandiDos invested in XXX companies to date.
ScandiDos made its latest investment on XXXXXXXX, XXXXX. ScandiDos invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by ScandiDos
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ScandiDos
| When was ScandiDos founded? | ScandiDos was founded in 2001. |
| Where is ScandiDos headquartered? | ScandiDos is headquartered in Sweden. |
| How many employees does ScandiDos have? | As of today, ScandiDos has over 26 employees. |
| Is ScandiDos publicly listed? | Yes, ScandiDos is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of ScandiDos? | ScandiDos trades under SDOS ticker. |
| When did ScandiDos go public? | ScandiDos went public in 2014. |
| Who are competitors of ScandiDos? | ScandiDos main competitors are Spineway, Neola Medical, Bio-Gate, Qlife Holding. |
| What is the current market cap of ScandiDos? | ScandiDos' current market cap is $6M. |
| What is the current revenue of ScandiDos? | ScandiDos' last fiscal year revenue is $7M. |
| What is the current EV/Revenue multiple of ScandiDos? | Current revenue multiple of ScandiDos is 0.8x. |
| Is ScandiDos profitable? | No, ScandiDos is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.